Global Continence Care Market Poised for Growth as Aging Population and Advanced Catheter Technologies Increase Demand
Global Continence Care Market Overview
The Global Continence Care Market is experiencing sustained growth as healthcare systems respond to the rising prevalence of urinary and fecal incontinence, an expanding geriatric population, and increasing cases of chronic diseases and neurological disorders. According to Maximize Market Research, the market was valued at USD 23.17 billion in 2025 and is expected to reach USD 34.15 billion by 2032, registering a CAGR of 5.7% during 2026–2032. The growing incidence of diabetes is another important market driver because diabetes can damage nerves involved in bladder control. Spinal cord injuries, spina bifida, benign prostate hyperplasia, pregnancy-related conditions, childbirth, and age-related functional impairment are also contributing to demand for continence-care solutions. At the same time, greater awareness of bladder and bowel management and improvements in healthcare infrastructure are encouraging patients to seek professional treatment. The market presents opportunities for manufacturers developing comfortable, discreet, biocompatible, and easy-to-use products. Advanced catheter materials, compact designs, improved lubrication, infection-reduction technologies, and solutions that support independent home-based care are expected to strengthen future market development. However, low-cost alternatives, limited awareness in some markets, and social stigma surrounding incontinence remain challenges.
* Download the Full Market Report: https://www.maximizemarketresearch.com/request-sample/92626/
US Market Trends and Investment
The United States remains a major growth market, supported by advanced healthcare infrastructure, favorable reimbursement conditions, an aging population, and increasing demand for home-based continence care. In 2025, ConvaTec reported particularly strong momentum in its Continence Care business, with first-half revenue reaching $259 million, representing 7.0% growth on both a reported and constant-currency basis and 6.7% organic growth. The company said U.S. volume growth and market-share gains were key contributors, while its compact GentleCath Air for Women catheter continued to receive positive customer and healthcare-professional feedback. ConvaTec also announced plans for more than $1 billion in R&D-facility investment, including a 50% expansion of its Boston, U.S., R&D facilities by the end of 2025. These investments demonstrate the industry's focus on product innovation, catheter design, and technologies addressing unmet needs in chronic care.
Market Segmentation
According to Maximize Market Research, Urinary Incontinence is the leading type segment and is expected to grow at a 7.5% CAGR during the forecast period. Its dominance is linked to the high prevalence of urinary incontinence among older adults, particularly those experiencing comorbidities, functional limitations, and cognitive impairment. By product, Urinary Catheters represent the segment with significant growth potential. Intermittent and indwelling urethral catheters are increasingly used for bladder management, while biocompatible materials such as silicone can help reduce complications associated with catheter use.
Key Players
C.R. Bard, Inc.
Medtronic
ConvaTec Group PLC
Coloplast Group
Dentsply Sirona
Kimberly‑Clark Corporation
Medical Technologies of Georgia
Boston Scientific Corporation
B. Braun Melsungen AG
Hollister Incorporated
Victoria Healthcare Products
Multipoint Technologies Pty Ltd (Medshop Australia)
McFarlane Medical Equipment (Holdings) Pty Ltd
Salts Healthcare Ltd.
Torbot Group, Inc.
Unicharm Corporation
ABENA A/S
Attends Healthcare Products, Inc.
Paul Hartmann AG
Ontex International N.V.
Medline Industries, Inc.
Cardinal Health, Inc.
First Quality Enterprises, Inc.
Procter & Gamble Co.
Essity AB (TENA brand)
Competitive Analysis
The MMR report identifies C.R. Bard, Inc., Medtronic, ConvaTec Group PLC, Coloplast Group, Dentsply Sirona, Kimberly-Clark Corporation, Medical Technologies of Georgia, Boston Scientific Corporation, B. Braun Melsungen AG, Hollister Incorporated, Victoria Healthcare Products, Salts Healthcare Ltd., Torbot Group, Unicharm Corporation, ABENA A/S, Attends Healthcare Products, Paul Hartmann AG, Ontex International, Medline Industries, Cardinal Health, First Quality Enterprises, Procter & Gamble, and Essity among the companies covered. The supplied report does not disclose individual numerical market shares, so a definitive top-five ranking by market share cannot be stated without making unsupported assumptions.
C.R. Bard is an established participant in urinary drainage and catheter technologies, with its capabilities now integrated into BD's broader medical-device portfolio. Continued emphasis on catheter safety and infection prevention supports market development.
Medtronic brings expertise in advanced medical technologies and neuromodulation, creating opportunities for technology-driven approaches to bladder-control disorders and broader continence management.
ConvaTec Group is investing substantially in continence-care innovation. Its GentleCath Air for Women compact catheter has continued to gain traction, while the company's expanded R&D infrastructure in Boston is designed to strengthen innovation across chronic-care categories.
Coloplast Group remains a major continence-care specialist, with product development focused on catheter usability, comfort, discretion, and patient independence. Its established presence in intermittent catheterization supports continued innovation in home-based bladder management.
Hollister Incorporated offers a broad portfolio of intermittent catheters and urine-collection products. Its current portfolio includes VaPro no-touch catheters, Infyna Chic catheters designed with women in mind, and products incorporating hydrophilic lubrication and rounded eyelets to improve usability.
Regional Analysis
United States: North America is expected to remain one of the dominant regional markets. Advanced healthcare facilities, technologically developed continence-care products, favorable reimbursement policies, and an aging population are supporting demand. Strong U.S. investment in home-based services and catheter innovation is further strengthening the market.
United Kingdom: The UK offers significant opportunities through its established healthcare system and increasing focus on improving continence management and patient quality of life. Greater emphasis on value-based healthcare can encourage adoption of products that reduce complications and improve patient independence.
Germany: Germany benefits from advanced medical infrastructure, an aging population, and strong demand for high-quality medical devices. The country's healthcare system provides favorable conditions for advanced catheter and continence-management technologies.
France: France's developed healthcare infrastructure and growing elderly population support demand for continence products. Increased awareness and improvements in home healthcare can further expand adoption.
Japan: Japan presents strong long-term opportunities because of its rapidly aging population. Increasing demand for products that support independent living and home-based care is expected to encourage continence-care adoption.
China: China represents a substantial emerging opportunity because of its large population, improving healthcare infrastructure, and expanding access to advanced medical products. Rising awareness of continence disorders and improvements in elderly care can accelerate market penetration.
Conclusion
The Global Continence Care Market is projected to increase from USD 23.17 billion in 2025 to USD 34.15 billion by 2032, expanding at a 5.7% CAGR. In my view, the strongest growth opportunities will come from advanced urinary catheters, biocompatible materials, compact and discreet designs, home-based continence management, and patient-friendly technologies. The combination of population aging and rising chronic disease prevalence will create sustained underlying demand, while R&D investment can improve comfort, safety, and independence. Manufacturers that prioritize easy-to-use products, infection prevention, personalized solutions, and discreet designs will be well positioned to capture the next phase of growth in the global continence-care industry.
About Maximize Market Research
Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.
Contact Maximize Market Research
MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
? +91 9607365656
? sales@maximizemarketresearch.com
